Monday December 9, 2019
Home Lead Story Chile Survive...

Chile Survives Through Major Quake With Little Damage

Chile is located along the so-called Ring of Fire, which makes it one of the most seismic countries in the world.

0
//
Chile
Boats lifted by an earthquake-triggered tsunami sit on a dock, in Coquimbo, Chile, Sept. 18, 2015. A magnitude 6.7 quake struck the city Jan. 19, 2018, but no tsunami was generated. VOA

A 6.7-magnitude earthquake has shaken cities on Chile’s northern coast. No damages have been reported so far, but Chile’s National Emergency Office ordered a preventative evacuation of a stretch of coast near the city of Coquimbo.

Chilean authorities said the quake didn’t have the characteristics that would generate a tsunami. The U.S. Tsunami Warning System also ruled out a tsunami.

The U.S. Geological Survey said the epicenter of the magnitude-6.7 quake was 15.6 kilometers (9.7 miles) south-southwest of Coquimbo, and had a depth of 53 kilometers. It struck at 7:32 p.m. local time.

Chile
Earthquake epicenter

A witness told Reuters there was minor damage to older buildings and power outages in the nearby coastal city of La Serena, a popular beach town about 400 kilometers (250 miles) north of Santiago.

“It felt very strong … the tourists were very nervous, but nothing serious happened,” Camila Castillo, a receptionist at a hotel in La Serena, told Reuters.

Chilean miner Antofagasta Plc said operations were normal at its Los Pelambres copper mine following the nearby earthquake.

Also Read: Amazon.com In Talks With Chile To Create A Ground For Developing Artificial Intelligence

Chile is located along the so-called Ring of Fire, which makes it one of the most seismic countries in the world.Chile is located along the so-called Ring of Fire, which makes it one of the most seismic countries in the world. An 8.8-magnitude earthquake and ensuing tsunami in 2010 killed 525 people. (VOA)

Next Story

Philadelphia Jury Awards $8 Billion in Punitive Damages against Johnson & Johnson

Johnson and Johnson immediately denounced the award after the jury's decision in the Court of Common pleas, saying it's "excessive and unfounded"

0
Philadelphia, Jury, Damages
FILE - The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, May 29, 2019. VOA

A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff’s attorneys say is linked to the abnormal growth of female breast tissue in boys.

Johnson and Johnson immediately denounced the award after the jury’s decision in the Court of Common pleas, saying it’s “excessive and unfounded” and vowing immediate action to overturn it.

The antipsychotic drug Risperdal is at the center of the lawsuit, with the plaintiff’s attorneys arguing it’s linked to abnormal growth of female breast tissue in boys, an incurable condition known as gynecomastia.

Johnson & Johnson used an organized scheme to make billions of dollars while illegally marketing and promoting the drug, attorneys Tom Kline and Jason Itkin said in a statement.

Philadelphia, Jury, Damages
A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made. Pixabay

Kline and Itkin said that Johnson & Johnson was “a corporation that valued profits over safety and profits over patients.” Thousands of lawsuits have been filed over the drug, but the attorneys said this was the first in which a jury decided whether to award punitive damages and came up with an amount.

Johnson & Johnson said in a statement on its website it was confident that the award would be overturned, calling it “grossly disproportionate” with the initial compensatory damage award and “a clear violation of due process.”

Johnson & Johnson said the court’s exclusion of key evidence left it unable to present a meaningful defense, including what they said was a drug label that “clearly and appropriately outlined the risks associated with the medicine” or Risperdal’s benefits for patients with serious mental illness. They also said the plaintiff’s attorneys failed to present any evidence of actual harm.

Also Read- Three Scientists Win Nobel Prize in Chemistry for their Contributions to Development of Lithium-Ion Batteries

“This decision is inconsistent with multiple determinations outside of Philadelphia regarding the adequacy of the Risperdal labeling, the medicine’s efficacy, and findings in support of the company,” Johnson & Johnson said. “We will be immediately moving to set aside this excessive and unfounded verdict.” (VOA)